HCPLive

Top Medical News Today

Colonoscopies: Fasting May Not Be Necessary
The overwhelming experience of preparing for colonoscopies may no longer have to be tolerated on an empty stomach.
Studying the use of targeted medicines in psychiatry is still new but early studies have shown that this could be a viable treatment option in the future for some patients in need.
In the field of oncology the use of targeted medications is becoming more commonplace to address various conditions. Research is being done in other areas of medicine, including psychiatry to see if there is more that can be done to address this patient population as well.
The development of new medications for any condition requires attention to detail in a number of areas, especially safety and efficacy. A recent drug developed for irritable bowel syndrome (IBS) looked to be effective in both areas prior to its approval.
Patients with diabetes face several challenges when it comes to coronary surgery success for numerous conditions. A recent study looked at the impact diabetes has on the success of coronary bypass grafts.
Researchers reported that SVR12 rates in real-world, post-transplant genotype 1 HCV patients treated with ledipasvir-sofosbuvir, with or without ribavirin, is 98% across regimens and various characteristics.
Researchers report promising results from the QUARTZ-I study that assessed the efficacy of the 3D regimen combined with sofosbuvir in treatment-experienced patients with HCV genotype 1 infection.
Results from the ION-3 trial showed that the rapidity and durability of viral suppression achieved with ledipasvir-sofosbuvir therapy allows a shorter treatment course of 8 weeks in genotype 1, treatment-naïve, non-cirrhotic patients.
As more women take leadership roles in gastroenterology and , it can go a long way in helping to bridge the gender gap in that other specialties in medicine.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$